Skip to main content

Prescription medicine

Silver sulfadiazine Brand names: Ssd, Silvadene, Thermazene

Silver sulfadiazine (Ssd) is a prescription medicine with an FDA approval on record since 1973. No generic is listed; pharmacies paid $0.260 per gram (Silver sulfadiazine 1% cream) in the October 7, 2026 NADAC survey.

  • No generic listed

Check it at the source: the silver sulfadiazine FDA label on DailyMed (effective April 24, 2019, Dr Reddys Laboratories Inc); the NDA 17381 record on Drugs@FDA; every silver sulfadiazine label on DailyMed.

Highlights of the record

FDA label of April 24, 2019; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026

Used for

From the label: indications and usage

Silver Sulfadiazine Cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.

Forms and strengths

  • 10 mg/g
  • 10 g/1000g

Cream.

On the market

Earliest approval on file
November 26, 1973 Silvadene, King Pharms Llc; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
No generic approved
Labelers listed (NDC)
14 of which 0 under generic applications, 13 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
$0.260 per gram Silver sulfadiazine 1% cream
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
2,276 through July 30, 2026

What is silver sulfadiazine used for?

From the label: indications and usage

Silver Sulfadiazine Cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.

FDA pharmacologic class: Sulfonamide Antibacterial.

Source: FDA drug label (SSD Cream), Dr Reddys Laboratories Inc, effective April 24, 2019 (SPL set 30d6dc33-e457-466b-9159-d8e7cd791820), via openFDA; the full label on DailyMed

Is there a generic for silver sulfadiazine (Ssd)?

No generic silver sulfadiazine is approved (Drugs@FDA, October 8, 2026).

  • 1973 earliest approval on file

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What do pharmacies pay for silver sulfadiazine (Ssd)?

In CMS's NADAC survey of October 7, 2026, pharmacies paid $0.260 per gram (Silver sulfadiazine 1% cream), up 29% from $0.202 on October 8, 2025. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.

  • Silver sulfadiazine 1% cream (generic)
  • Silvadene 1% cream (brand)
$0.260
$0.111
January 2024October 2026
NADAC per unit, October 7, 2026
Strength and formBrand or genericPharmacy cost30 tablets, or one pen or vial12-month change
Silver sulfadiazine 1% creamGeneric$0.260 per gramn/a+29%
Ssd 1% creamGeneric$0.260 per gramn/a+28%
Silvadene 1% creamBrand$0.252 per gramn/a+2%

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What do FAERS reports show for silver sulfadiazine?

The FDA Adverse Event Reporting System holds 2,276 reports that list silver sulfadiazine among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 291 are coded as a death and 784 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

Reports received each year

The most reported reactions

  • Off Label Use (a use or a product term, not a reaction)157
  • Pain154
  • Fatigue152
  • Product Use In Unapproved Indication (a use or a product term, not a reaction)142
  • Nausea138
  • Death (an outcome recorded in the report)122
  • Diarrhoea119
  • Drug Ineffective (a use or a product term, not a reaction)112

Side effects: the label's list and every FAERS reaction

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Other sulfonamide antibacterials
the pharmacologic class, with prices and generics
Silver sulfadiazine side effects
the label's list beside FAERS reports
Check an interaction
what two or more labels say about each other